| Entry |
|
|---|
| Name |
Indeglitazar (USAN) |
|---|
| Formula |
C19H19NO6S
|
|---|
| Exact mass |
389.0933
|
|---|
| Mol weight |
389.42
|
|---|
| Structure |
|
|---|
| Class |
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01732 Non-thiazolidinedione type PPAR agonist
|
|---|
| Efficacy |
Antidiabetic, Peroxisome proliferator-activated receptor (PPAR) agonist |
|---|
| Comment |
Treatment of type II diabetes
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01732 Non-thiazolidinedione type PPAR agonist
D09350 Indeglitazar
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C (PPAR)
D09350 Indeglitazar (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 27
1 C8x C 11.5500 -23.3100
2 C8y C 11.5500 -24.7100
3 C8x C 12.7400 -25.4100
4 C8x C 14.0000 -24.7100
5 C8y C 14.0000 -23.3100
6 C8x C 12.7400 -22.6100
7 O2a O 10.3600 -25.4100
8 C1a C 9.1700 -24.7100
9 S4a S 15.1900 -22.6100
10 N4y N 16.3800 -23.3100
11 C8y C 16.8000 -24.6400
12 C8y C 18.2000 -24.6400
13 C8y C 18.6900 -23.3100
14 C8x C 17.5700 -22.4700
15 C8x C 16.1000 -25.8300
16 C8x C 16.7300 -27.0900
17 C8y C 18.2000 -27.0900
18 C8x C 18.9000 -25.9000
19 O2a O 18.8300 -28.3500
20 C1a C 20.2300 -28.3500
21 O3c O 14.4900 -21.4200
22 O3c O 15.8900 -21.4200
23 C1b C 19.8800 -22.6100
24 C1b C 21.0700 -23.3100
25 C6a C 22.2600 -22.6100
26 O6a O 23.4500 -23.3100
27 O6a O 22.2600 -21.2100
BOND 29
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 7 8 1
9 5 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 2
15 10 14 1
16 11 15 2
17 15 16 1
18 16 17 2
19 17 18 1
20 12 18 2
21 17 19 1
22 19 20 1
23 9 21 2
24 9 22 2
25 23 24 1
26 23 13 1
27 24 25 1
28 25 26 1
29 25 27 2
|
|---|
